Hormonal control of insulin-like growth factor-binding protein-5 production in the involuting mammary gland of the rat

被引:133
作者
Tonner, E
Barber, MC
Travers, MT
Logan, A
Flint, DJ
机构
[1] HANNAH RES INST,AYR KA6 5HL,SCOTLAND
[2] UNIV BIRMINGHAM,DEPT MED,BIRMINGHAM B15 2TT,W MIDLANDS,ENGLAND
关键词
D O I
10.1210/en.138.12.5101
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
We have demonstrated a 50-fold increase in the concentration of insulin-like growth factor binding protein-5 (IGFBP-5) in milk after 2 days of mammary involution induced by removal of the suckling young. IGFBP-5 was identified by its immunoreactivity with an antiserum to IGFBP-5 and was shown by in situ hybridization to be synthesized by the secretory epithelial cells undergoing apoptosis. Smaller increases in IGFBP-2 and -4 messenger RNAs (mRNAs) were also evident, but neither protein could be detected on Western ligand blots of milk. Preliminary evidence failed to detect mRNAs for IGFBP-1, -3, or -6. The large increase in IGFBP-5 concentrations in milk from involuting mammary glands was inhibited by 90% if the dams received concurrent PRL injections for 2 days, but was unaffected by GH, progesterone, corticosterone, or an antiserum to insulin-like growth factor I (IGF-I). In lactating rats allowed to continue nursing their young, 17 beta-estradiol failed to affect IGFBP-5; concentrations, whereas in animals that had half the teats sealed to prevent milk removal, IGFBP-5 concentrations increased 5- to 10-fold in the sealed gland compared with those in the contralateral gland where milk removal continued. The changes in IGFBP-5; concentrations in milk were accompanied by similar changes in steady state mRNA levels of IGFBP-5 in mammary tissue. We have previously shown that PRL inhibits apoptosis and involution of the mammary gland, whereas teat sealing has the opposite effect. We, therefore, propose that IGFBP-5 serves to inhibit IGF-I-mediated cell survival, but that it is normally suppressed by PRL and milk removal. Although IGFBP-5-when bound to extracellular matrix, augments the action of IGF, we believe that in the involuting mammary gland IGFBP-5 inhibits IGF action by interacting with casein micelles, which contain calcium phosphate nanoclusters, thereby preventing IGF interaction with IGF receptors. This is analogous to the interaction of IGFBP-5 with hydroxyapatite, which serves to sequester IGFs in bone. IGFBP-5 may, in fact, play a central role in inducing apoptosis, as it is also up-regulated in involuting prostate and thyroid glands as well as in atretic ovarian follicles.
引用
收藏
页码:5101 / 5107
页数:7
相关论文
共 42 条
[1]  
ANDRESS DL, 1995, J BIOL CHEM, V270, P28289
[2]   GLYCOSAMINOGLYCANS INHIBIT DEGRADATION OF INSULIN-LIKE GROWTH FACTOR-BINDING PROTEIN-5 [J].
ARAI, T ;
ARAI, A ;
BUSBY, WH ;
CLEMMONS, DR .
ENDOCRINOLOGY, 1994, 135 (06) :2358-2363
[3]   THE ROLE OF GROWTH-HORMONE, PROLACTIN AND INSULIN-LIKE GROWTH-FACTORS IN THE REGULATION OF RAT MAMMARY-GLAND AND ADIPOSE-TISSUE METABOLISM DURING LACTATION [J].
BARBER, MC ;
CLEGG, RA ;
FINLEY, E ;
VERNON, RG ;
FLINT, DJ .
JOURNAL OF ENDOCRINOLOGY, 1992, 135 (02) :195-202
[4]   GROWTH-HORMONE PROLACTIN INTERACTIONS IN THE REGULATION OF MAMMARY AND ADIPOSE-TISSUE ACETYL-COA CARBOXYLASE ACTIVITY AND GENE-EXPRESSION IN LACTATING RATS [J].
BARBER, MC ;
TRAVERS, MT ;
FINLEY, E ;
FLINT, DJ ;
VERNON, RG .
BIOCHEMICAL JOURNAL, 1992, 285 :469-475
[5]  
BOONYARATANAKOR.V, 1996, 10 INT C END SAN FRA
[6]  
BOOTH BA, 1995, GROWTH REGULAT, V5, P1
[7]  
BRADSHAW SL, 1996, 10 INT C END SAN FRA
[8]  
DAVIS LG, 1986, BASIC METHODS MOL BI, P143
[9]  
DEEKS S, 1988, EXP CELL RES, V174, P443
[10]   INSULIN-LIKE GROWTH-FACTOR (IGF)-I AND RETINOIC ACID INDUCE THE SYNTHESIS OF IGF-BINDING PROTEIN-5 IN RAT OSTEOBLASTIC CELLS [J].
DONG, Y ;
CANALIS, E .
ENDOCRINOLOGY, 1995, 136 (05) :2000-2006